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In patients prescribed long-term oxygen therapy (LTOT), compliance is often poor. Both patient- and treatment- 
related factors seem to be involved. As a base for improvements in LTOT, the characteristics and complaints of 
LTOT patients were investigated. 
A survey was set up in a random sample of clients of the largest oxygen company in the Netherlands. Patients were 
selected if they were 2 18 years old, had a phone and if they had had oxygen equipment for 2 6 months, All patients 
were visited at home by a medical student. Data are presented for a total of 528 patients (response rate 62%). The 
typical LTOT patient was a 70-year-old male with chronic obstructive pulmonary disease (COPD), who had had 
oxygen equipment for 3.5 years and who used oxygen cylinders and nasal cannulae for 13 h day- i. Twenty percent 
of the patients still smoked. Although LTOT was prescribed in 80% of the patients by a chest physician, prescription 
was often inadequate. Only 33% of the patients were informed adequately about the therapy. Twenty percent of the 
patients used oxygen for fewer hours per day than prescribed. Non-compliant patients were mainly men (P=O.O06) 
and more often ashamed of their therapy (P=O.O23) than compliant patients. The blood oxygen level was monitored 
regularly in 73% of the patients. Most complaints concerned the oxygen equipment, especially the concentrator. The 
single most important complaint had to do with restricted autonomy. Only 19% of the patients had no complaints 
at all. 
It is concluded that LTOT should be improved with regard to the education, motivation and monitoring of 
patients. The prescribing physician needs to be included in an education programme. Given the numerous problems 
these patients experience, LTOT should be improved in particular with regard to equipment convenience. 
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Introduction 
In patients with chronic obstructive pulmonary disease 
(COPD) and chronic hypoxaemia, long-term oxygen 
therapy (LTOT) improved survival and reduced clinical 
deterioration over a 3-year period (1,2). An effect was only 
demonstrated if oxygen was used for at least 15 h day - ‘, 
with greater benefit for longer periods. International guide- 
lines, therefore, recommend the prescription of 15 h day- i 
as a minimum (3,4). However, if LTOT is prescribed 
according to these guidelines, it imposes a considerable 
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burden on many patients. Consequently, compliance to 
treatment is poor (5-7). Compliance may, amongst other 
factors, be affected by patient characteristics, such as moti- 
vation and severity of disease symptoms, information about 
the disease and the therapy, and, especially, by the per- 
ceived discomfort of the treatment itself (5-8). Attempts to 
improve compliance should, therefore, be based on knowl- 
edge of the characteristics and the complaints of these 
patients. 
In 1991, data on the characteristics and complaints of 
LTOT patients in the Netherlands were lacking. At the 
same time, relevant epidemiological data in the literature 
often originated from (chest) physicians instead of patients, 
contained only a small number of patients, and differed 
from country to country (9-12). Moreover, studies looking 
into the complaints of LTOT patients were scarce. This all 
led to the aim of the present study, namely to investigate the 
characteristics and complaints in patients who had been 
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TABLE 1. Patient-reported diagnoses and prescribing physicians (n=528) 
Diagnosis CP NCP GP Total 
COPD 
Pneumoconiosis 
Cluster headache 
Cardiovascular diseases 
Pulmonary fibrosis 
Lung cancer 
Dyspnoea 
Pulmonary emboli 
Cystic fibrosis 
Thoracic deformity cage 
Sclerodermia 
Other 
No diagnosis reported 
All patients 
315 (85%) 16 (4%) 38 (10%) 369 (70%) 
24 (75%) 1 (3%) 7 (22%) 32 (6%) 
1 (4%) 21 (88%) 2 (8%) 24 (4%) 
5 (42%) 3 (25%) 4 (33%) 12 (2%) 
10 (91%) 1 (9%) 11 (2%) 
5 (100%) 5 (1%) 
2 (50%) 2 (50%) 4 (1%) 
3 (100%) 3 (1%) 
3 (100%) 3 (1%) 
3 (100%) 3 (1%) 
3 (100%) 3 (1%) 
33 (89%) 1 (3%) 3 (8%) 37 (7%) 
17 (77%) 2 (9%) 3 (14%) 22 (4%) 
421 (80%) 49 (9%) 58 (11%) 528 (100%) 
CP, chest physician; NCP, non-chest physician; GP, general practitioner; COPD, chronic obstructive 
pulmonary disease. 
prescribed LTOT in the Netherlands. These data might 
allow for comparisons with data of LTOT patients in 
other countries, and could possibly serve as a base for 
improvements in LTOT. 
Methods 
To avoid biased patient selection, a survey was set up in a 
sample of 4500 clients of the largest oxygen company in the 
Netherlands (Hoek Loos). For reasons of travelling dis- 
tances, the file was restricted to 2523 patients. After they 
had been coded by number, 1381 of them were randomized 
by computer. The selection criteria were: (a) being 2 18 
years old; (b) having a phone; and (c) having oxygen 
equipment for 26 months. Eligible patients received an 
explanatory letter together with a reply card from the 
oxygen company. The name and phone number of a patient 
were only handed to the investigators if the card stated a 
positive reply. The patient was then phoned to arrange a 
home visit by a medical student. All patients were visited 
between 1 October, 1991 and 1 April, 1992. 
Prior to the visit, 15 students had been trained in 
formulating the 145 questions of a structured questionnaire, 
which referred to demographic data, the prescribing phys- 
ician, the illness, smoking habits and mobility. Prescription, 
usage, equipment, follow-up and coping with treatment 
were examined in detail. Students were instructed that all 
questions had to be answered by the patients themselves. 
To estimate the representativeness of the patient sample, 
the oxygen company was requested to complete two 
additional questionnaires. One for the patients who had 
been interviewed and given informed consent, and one for 
the patients who had refused the interview. The former 
questionnaire only referred to the amounts of daily oxygen 
prescribed and used, whereas the latter also referred to age: 
diagnosis, sex, duration of LTOT, smoking habits and 
oxygen source. For reasons of privacy, the latter set of 
questions had to be answered anonymously. Finally, 1 year 
after the last interview, the number of eligible patients 
who had died was extracted from the file of the oxygen 
company. The study was approved by the Medical Ethics 
Committee of the University Hospital Utrecht. 
STATISTICAL ANALYSIS 
Data analysis and descriptive statistics were performed 
using the SPSS/PC+program (SPSS Inc., Chigaco, U.S.A.). 
Subgroups were compared using t-tests and Mann-Whitney 
U-tests for continuous variables, and by x2 tests in contin- 
gency tables for categorical variables. Continuous values 
are reported as mean & standard deviation; all P values 
relate to two-tailed comparisons and were considered 
statistically significant if cO.05. 
Results 
Of the 895 patients selected, 341 (38%) refused to partici- 
pate. Twenty-six of the remaining 554 patients could not be 
interviewed for reasons of severe illness or early death. 
Therefore, data are presented for 371 men (70%) and 157 
women, with a median age of 70 years (range 19,8-91.9), 
who had been on LTOT for a mean of 3.5 i 3.6 (0.5-33.0) 
years. The patients’ diagnoses for which LTOT had been 
prescribed are listed in Table 1. There were 350 ex-smokers. 
Of the 108 smokers, 75 (69%) had a lung disease and 15 
smoked while using oxygen. Eighty-nine patients (17%) 
were housebound and 117 (22%) lived alone. In 389 patients 
(76%), the costs of LTOT were reimbursed by the Dutch 
National Health Service; the remaining patients were 
privately insured. 
In 421 patients (SO%), LTOT was prescribed by a chest 
physician; in 58 (1 l%), by a general practitioner; and in 49 
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TABLE 2. Frequency of patients’ complaints about their 
oxygen source 
Oxygen cylinders (n=421) 34% 
Transport of the cylinders 20% 
Changing the pressure valve 18% 
Size and appearance of the cylinders 5% 
Frequent deliveries 3% 
Oxygen concentrator (n = 76) 55% 
Vibrations and/or noise (46 dBA) 45% 
Technical problems 41% 
Power failure(s) 23% 
Transportation problems 10% 
Condensation in the oxygen hose 7% 
Fragility of the machine 1% 
Liquid oxygen (n =20) 35% 
Chance of frostbite 20% 
Dependency on the stationary canister 10% 
Need for sufficient ventilation 5% 
(9”/0), by a non-chest physician (internist, cardiologist, 
neurologist or E.N.T. specialist) (Table 1). Dyspnoea and 
hypoxaemia were the most important reasons for starting 
LTOT, in 243 (46%) and 196 patients (37%), respectively. 
Dyspnoea reduced after LTOT had begun in 34% of 479 
patients. Only 175 patients (33%) stated that they had been 
given instructions for the use of oxygen, generally by the 
oxygen company. 
The oxygen prescription and usage were unknown to 202 
and 32 patients, respectively. In the remaining patients, 
oxygen was prescribed for 15.8 5 7.4 h day - i and used for 
12.7 & 8-O h day - ‘. The mean of the individual differences 
between the amounts of daily oxygen prescribed and used 
was -0.6*3.2h day-’ (n = 324). Sixty-four patients 
(20%) used oxygen for less hours per day than prescribed 
because of the difficulties they experienced with the treat- 
ment, absence of dyspnoea or fear of becoming addicted to 
oxygen. Compared to the compliant patients, the non- 
compliant patients were more frequently males (P=O.O06) 
and were more often ashamed of their therapy (P=O.O23). 
Compliant and non-compliant patients did not differ sig- 
nificantly with respect to age, diagnosis, duration of LTOT, 
oxygen source, smoking cessation, and number and type of 
complaints (other than shame). 
A total of 430 patients (8 1%) used oxygen cylinders (10 1, 
20 kg); 71 (13%) used a MC 44 oxygen concentrator 
(DeVilbiss Healthcare, U.S.A.); 19 (4%) used liquid oxygen; 
and eight (2%) used a combination of these. Patients using 
a concentrator complained more often about their equip- 
ment than patients using either cylinders or liquid oxygen 
(P<O.OOl) (Table 2). Of the 316 patients (63%) who had 
received portable cylinders, 86 (27%) did not use them at 
all, 54 (16%) used them sporadically and only 19 (18%) 
carried the cylinders themselves. 
Nasal cannulae were used by 435 patients (82%), a nasal 
catheter by 49 (9%), a face mask by 16 (3%), a cuffed nasal 
catheter by 15 (3%), a combination of these by seven 
(lo%), and a transtracheal microcatheter by six patients 
Nose complaints 25 
Crusts in nose - 13 
Ear complaints m 9 
Nose bleeding B 8 
Throat complaints m 5 
Exanthema m 4 
Other m 3 
LOSS during sleep n 2 
Slashes 1 1 
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FIG. 1. Complaints due to the oxygen delivery device 
(n= 528). 
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FIG. 2. Categories of complaints due to long-term oxygen 
therapy (LTOT) (n= 528). 
(1%). A total of 212 patients (40%) had frequently occur- 
ring complaints due to their oxygen delivery device (Fig. 1). 
All complaints could be divided into five categories 
(Fig. 2). Most complaints concerned the oxygen equipment, 
of which the single most important problem was restricted 
autonomy. Only 19% of the patients did not have any 
complaints at all (Fig. 3). 
LTOT monitoring in the outpatient department was 
performed in 451 patients (85%). In 387 patients (73%), the 
blood oxygen level was checked regularly by means of 
arterial blood gas analysis (73%), capillary blood gas analy- 
sis (14%), pulse oximetry (1%) or by a combination of these 
(12%). A total of 129 patients (24%) were visited at home, 
mostly by a general practitioner, a district nurse or a 
physiotherapist. 
To test the representativeness of the patient sample, a 
selection of their data was compared to data of the 341 
non-respondents. Except for the daily amounts of oxygen 
prescribed and used, which were supplied by the oxygen 
company together with the data on the non-respondents, 
information was given by the patients themselves. With the 
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FIG 3. Number of categories of complaints due to long- 
term oxygen therapy (LTOT) (n=.%%). 
exception of compliance, all data differed significantly 
(Table 3). Adding the 26 drop-outs did not influence the 
result. 
Discussion 
This study documents that in patients using LTOT, 
complaints due to this therapy are very common. Most 
discontent was related to the equipment. As has been 
demonstrated by others, patients who use a concentrator 
are troubled most (13-15). Comparison with other studies 
is, however, difficult as studies that have looked into the 
complaints of LTOT patients are scarce. Moreover, in the 
few studies available, patients were rarely directly asked for 
negative experiences. 
In addition, this study shows that in the Netherlands, the 
typical LTOT patient is a 70-year-old male COPD patient 
who has had oxygen equipment for 35 years and who has 
been using oxygen cylinders and nasal cannulae for a mean 
of 13 h day - i. Although this is, in many respects, in 
agreement with findings from other countries, there are 
some differences which make it difficult to transfer the 
present results to those of other countries (g-12,16-18). For 
example, in Scotland and Sweden, the mean age of patients 
was somewhat lower (9,18). This may be due to an earlier 
start of LTOT in these countries due to the implementation 
of clear guidelines. In France and Sweden, oxygen was 
prescribed in l&24% of the LTOT patients because of 
hypoxaemia due to sequelae of tuberculosis. In the 
Netherlands, this is rarely an indication for LTOT (9,19). 
In France, Poland, Sweden and Switzerland, most patients 
have oxygen concentrators, whereas in Italy, most patients 
use liquid oxygen (20,21). These differences may be 
explained by the local density and accessibility of patients, 
and by the reimbursement policies of each country. 
In the Netherlands, almost any physician is allowed to 
prescribe oxygen. As a result, 15% of the COPD patients 
were prescribed LTOT by a non-chest physician. Although 
mean oxygen prescription was in agreement with inter- 
national guidelines, the standard deviation was large, indi- 
cating that many patients were treated inadequately. In 
46% of the patients, dyspnoea was the most important 
reason to initiate LTOT. The fact that this therapy is not 
for symptomatic relief of dyspnoea and that this complaint 
is not always caused by hypoxaemia may explain why 
LTOT caused a reduction of dyspnoea in only 34% of the 
patients (22-24). Only 33% of the patients were informed 
about side-effects and the way oxygen had to be used. 
However, it is the duty of the prescribing physician to 
educate and motivate the patient in this respect (25,26). 
Twenty percent of the patients used oxygen for less hours 
than prescribed, mostly because of shame and absence of 
dyspnoea. Compliance was not related to the number or 
type of complaints, except for shame. Patients especially 
experienced difficulties when using oxygen during the day; 
only 31% used oxygen while walking indoors, 29% while 
eating, 21% while taking a bath or shower, and only 20% 
when going out. The latter may be attributed to shame and 
impaired mobility. The weight of the portable cylinder 
(5.5 kg) caused many patients to leave their oxygen at home 
when going out. For LTOT patients who are still ambulant, 
liquid oxygen might be a better alternative. In fact, the 
number of patients using liquid oxygen who went out while 
still connected to the equipment was higher than that of 
patients with portable cylinders (P=O.O02), which is in 
accordance with the literature (7,27). Most patients were 
monitored regularly, but encouragement to increase the 
daily oxygen use was only given to a minority of them. It is 
important, though, that patients with an accepted indi- 
cation for LTOT are urged to use oxygen for at least 15 h 
day - ’ (l-3). To assess oxygenation, blood gas analysis was 
used instead of pulse oximetry in 87% of the patients. 
Although pulse oximetry should not be used as a substitute 
for arterial oxygen tension measurements for LTOT pre- 
scription, it is an excellent means for checking LTOT 
patients (28,29). 
Despite the high incidence of significant disability 
observed, organized home care was lacking. The only 
structural support for the patients was through the oxygen 
company. A home care programme, with a nurse making 
home visits, may provide a better solution than regular 
visits to an outpatient department (7,15,21). 
There are some limitations to the present investigation. 
First, due to its random nature, several data may differ 
from objective data, especially with regard to prescription, 
usage and compliance. Patients usually tend to overestimate 
their oxygen usage, thus improving their compliance (7). 
Second, in order to exclude patients who used oxygen for 
palliative reasons, only patients having oxygen equipment 
for at least 6 months were selected. Next, data from the 
oxygen company were often missing or not up to date. 
Due to privacy regulations, data on the diagnosis, sex or 
smoking habits of the non-respondents were not available. 
Finally, the response rate of eligible patients was moder- 
ate. Since this reflects both the willingness and the ability to 
participate in the study, patients may have refused an 
interview because of the severity of their illness. The l-year 
mortality rate was in fact significantly higher in the non- 
respondents than in the respondents, even though the 
former were prescribed oxygen for less hours per day than 
the latter. This may be caused by the fact that the non- 
respondents were prescribed LTOT at a later stage in their 
disease or by inadequate prescription (13,30). Age may 
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TABLE 3. Comparison of some of the characteristics of the 528 respondents and 341 non-respondents 
Respondents (n = 528) Non-respondents (n = 341) P value 
Age (years) 68.4 f 11.1 (n=528) 70.2 3~ 11.0 (n=259) 0.03 
Duration of LTOT (years) 3.5 f 3.6 (n=523) 2.4 zt 2.1 (n=341) <O.OOl 
l-year mortality rate [no. (%)] 134 (25) (n=528) 141(42) (n=341) <O,OOl 
Prescription (1 day - ‘) 1371+ 1268 (n=239) 816 rt 808 (n=230) <O.OOl 
Consumption (1 day - ‘) 994zk 1346 (n=247) 592zt699 (n=203) <O.OOl 
Compliance (1 day - ‘) -228 f 1728 (n= 134) -210*684 (n=203) NS 
Oxygen source [no. (%)I 528 (100) (n=528) 205(100) (n=205) 0.03 
Cylinders [no. (%)I 430 (81) 183(89) 
Concentrator [no. (%)I 78 (15) 16@) 
Liquid oxygen [no. (%)I 20 (4) 
NS, not significant; LTOT, long-term oxygen therapy. 
h(3) 
have played a role as well, since 52% of the respondents 
compared to 62% of the non-respondents were over the age 
of 70 years (PcO.01). In addition, the poor l-year survival 
in the non-respondents may have been caused by a greater 
number of smokers and a different distribution of diseases 
(13,30). Despite the abovementioned factors, the patient 
sample of this study seems adequate as it represented 
almost 10% of the LTOT patients in the Netherlands, 
It is concluded that LTOT might be improved with 
regard to the education, motivation and monitoring of 
patients. The prescribing physician needs to be included in 
an education programme. Given the numerous problems 
these patients experience, LTOT should be improved, 
particularly with regard to equipment convenience. 
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